Immutep Receives Positive EMA Scientific Advice for Further Clinical Development of Efti in MBC Including Phase III
Positive feedback for the general clinical development program including the planned registrational Phase III trial in metastatic breast cancer (MBC) Other regulatory engagement ongoing, including with the US Food and Drug Administration (FDA) SYDNEY, AUSTRALIA, more...
O2Micro Reports Third Quarter 2021 Financial Results
GEORGE TOWN, Grand Cayman, Oct. 29, 2021 (GLOBE NEWSWIRE) — Operational Highlights: 2021 Q3 revenue was $27.3 million. Revenue increased 22.6% compared to the same quarter in 2020. GAAP net income was $0.12 per fully more...
GrowLife, Inc. Issues Letter to Shareholders
Company CEO Pens Letter to Investors Explaining New Direction as Picks and Shovels Focus for the Mushroom Industry Summary: · CEO explains new direction as the picks and shovels supplier to the burgeoning mushroom cultivation more...
Jushi Holdings Inc. to Open its 26th Store Nationwide and 2nd BEYOND / HELLO(TM) Retail Location in Virginia
BEYOND / HELLO™ Sterling, Located Only Seven Miles from Dulles International Airport, to Begin Serving Virginia Medical Cannabis Patients on Tuesday, November 2 nd at 10:00 a.m. Company Expands its Delivery Program to Meet Increasing more...
Lifeist Wellness Reports Continuing Improved Trends in Q3 2021
— Improvement in Key Metrics: Revenue Growth, Adj. Gross Profit, Operating Cashflow — Execution in Cannabis as Company Pursues Emerging Nutraceuticals Opportunity TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. ( “Lifeist” or more...
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23 Increases full-year 2021 financial guidance WINTER SPRINGS, Fla., Oct. 29, 2021 (GLOBE NEWSWIRE) — IRADIMED CORPORATION more...
Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update
BERKELEY HEIGHTS, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce third quarter financial more...
Affimed to Report Third Quarter 2021 Financial Results & Corporate Update on November 10, 2021
HEIDELBERG, Germany, Oct. 29, 2021 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release third more...
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare – Biotech segment of the equity market. Retail and institutional more...
Harvest One and its Brands LivRelief (TM) and Dream Water (TM) Report Positive Q4 2021 and Year End Financial Results
Strategic transformation to a uniquely positioned health and wellness company that provides top selling brands to the global marketplace Improved net revenue by 2.2% growth year over year despite aggressive COVID travel restrictions Improved gross more...